주산기 감염증 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 감염증 유형별, 치료법별, 진단별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Perinatal Infections Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Infection Type, By Treatment, By Diagnosis, By End user, By Region and Competition, 2020-2030F
상품코드:1878836
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 187 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 주산기 감염증 시장은 2024년에 16억 달러로 평가되었으며, 2030년까지 CAGR 5.30%로 성장하여 21억 8,000만 달러에 달할 것으로 예측됩니다.
세계 주산기 감염증 시장은 임신 중 또는 분만 시 모체에서 태아로 전파되는 바이러스 또는 세균에 의한 감염의 진단 및 치료 솔루션에 초점을 맞추고 있습니다. 시장 확대는 이러한 감염성 질환의 전 세계적인 유병률 증가, 의료비 지출 증가, 모자보건에 대한 대중의 인식이 높아짐에 따라 크게 촉진되고 있습니다. 또한, 진단법과 치료의 지속적인 기술 발전으로 조기 발견과 보다 효과적인 개입이 가능해져 더욱 성장할 수 있게 되었습니다.
The Global Perinatal Infections Market, valued at USD 1.6 Billion in 2024, is projected to experience a CAGR of 5.30% to reach USD 2.18 Billion by 2030. The Global Perinatal Infections Market focuses on diagnostic and therapeutic solutions for infections caused by viruses or bacteria transmitted from a mother to her fetus during gestation or childbirth. Market expansion is substantially driven by the increasing global prevalence of these infections, alongside rising healthcare expenditure and heightened public awareness concerning maternal and child health. Further growth is supported by continuous technological advancements in diagnostic methodologies and treatment modalities, facilitating earlier detection and more effective interventions.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 1.6 Billion
Market Size 2030
USD 2.18 Billion
CAGR 2025-2030
5.3%
Fastest Growing Segment
Hospitals & Clinics
Largest Market
North America
Key Market Drivers
The Global Perinatal Infections Market is significantly shaped by sustained technological advancements in diagnostics and treatment. Innovations in diagnostic platforms are continuously enhancing the precision and accessibility of early detection for perinatal infections. This includes the development of non-invasive prenatal tests, which allow for screening of complex fetal genetic conditions with reduced risk. For instance, according to Natera, in August 2025, their Fetal Focus test, a noninvasive prenatal test for inherited conditions, was launched, supported by data from a clinical trial that initiated in 2023 and had enrolled approximately 1,300 participants. These diagnostic breakthroughs enable earlier and more accurate identification of infections, facilitating timely intervention and improving outcomes for both mother and child.
Key Market Challenges
The scarcity of adequately skilled healthcare professionals capable of providing accurate diagnosis and comprehensive treatment for complex perinatal conditions significantly impedes the growth of the Global Perinatal Infections Market. This shortage directly limits the effective deployment and utilization of innovative diagnostic technologies and therapeutic solutions. When there are insufficient trained personnel, particularly those specializing in infectious diseases, the ability to promptly and accurately identify perinatal infections is compromised. This often leads to delayed treatment initiation, reduced efficacy of available interventions, and poorer maternal and neonatal outcomes.
Key Market Trends
The growing adoption of personalized medicine approaches represents a pivotal trend reshaping the Global Perinatal Infections Market by moving beyond standardized treatments to highly individualized care. This trend emphasizes tailoring diagnostic and therapeutic interventions based on a mother's unique genetic profile, microbial resistance patterns, and immune response, aiming to optimize outcomes for both mother and child. Such customization drives demand for advanced molecular diagnostics capable of identifying specific pathogens and host genetic predispositions with high precision. According to the Personalized Medicine Coalition, the FDA approved 18 new personalized medicines in 2024, constituting 38% of all newly approved therapeutic molecular entities across various treatment areas. Companies are increasingly collaborating in this space; Roche and Janssen Biotech Inc. joined forces in February 2023 to develop personalized and targeted therapies alongside companion diagnostics, signaling a strategic focus on this tailored medical paradigm.
Key Market Players
Merck KGaA
Beckman Coulter Inc.
Bio-Rad Laboratories, Inc
Hologic Inc.
Gilead Sciences, Inc.
Emcure Pharmaceuticals Limited.
Cipla Inc.
Bausch Health Companies Inc
Johnson & Johnson
Teva Pharmaceutical Industries Ltd.
Report Scope:
In this report, the Global Perinatal Infections Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Perinatal Infections Market, By Infection Type:
Cytomegalovirus Infection
Enterovirus Infection
Genital Herpes
Gonorrhoea
Human Immunodeficiency Virus
Listeriosis Lymphocytic Choriomeningitis Virus
Rubella
Syphilis
Varicella
Others
Perinatal Infections Market, By Treatment:
Antibiotics
Antiviral
Antiretroviral
Others
Perinatal Infections Market, By Diagnosis:
Maternal Test
Neonatal Test
Others
Perinatal Infections Market, By End user:
Hospitals & Clinics
Ambulatory Care Centers
Others
Perinatal Infections Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Perinatal Infections Market.
Available Customizations:
Global Perinatal Infections Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Perinatal Infections Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Infection Type (Cytomegalovirus Infection, Enterovirus Infection, Genital Herpes, Gonorrhoea, Human Immunodeficiency Virus, Listeriosis Lymphocytic Choriomeningitis Virus, Rubella, Syphilis, Varicella, Others)
5.2.2. By Treatment (Antibiotics, Antiviral, Antiretroviral, Others)
5.2.3. By Diagnosis (Maternal Test, Neonatal Test, Others)
5.2.4. By End user (Hospitals & Clinics, Ambulatory Care Centers, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Perinatal Infections Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Infection Type
6.2.2. By Treatment
6.2.3. By Diagnosis
6.2.4. By End user
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Perinatal Infections Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Infection Type
6.3.1.2.2. By Treatment
6.3.1.2.3. By Diagnosis
6.3.1.2.4. By End user
6.3.2. Canada Perinatal Infections Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Infection Type
6.3.2.2.2. By Treatment
6.3.2.2.3. By Diagnosis
6.3.2.2.4. By End user
6.3.3. Mexico Perinatal Infections Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Infection Type
6.3.3.2.2. By Treatment
6.3.3.2.3. By Diagnosis
6.3.3.2.4. By End user
7. Europe Perinatal Infections Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Infection Type
7.2.2. By Treatment
7.2.3. By Diagnosis
7.2.4. By End user
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Perinatal Infections Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Infection Type
7.3.1.2.2. By Treatment
7.3.1.2.3. By Diagnosis
7.3.1.2.4. By End user
7.3.2. France Perinatal Infections Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Infection Type
7.3.2.2.2. By Treatment
7.3.2.2.3. By Diagnosis
7.3.2.2.4. By End user
7.3.3. United Kingdom Perinatal Infections Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Infection Type
7.3.3.2.2. By Treatment
7.3.3.2.3. By Diagnosis
7.3.3.2.4. By End user
7.3.4. Italy Perinatal Infections Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Infection Type
7.3.4.2.2. By Treatment
7.3.4.2.3. By Diagnosis
7.3.4.2.4. By End user
7.3.5. Spain Perinatal Infections Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Infection Type
7.3.5.2.2. By Treatment
7.3.5.2.3. By Diagnosis
7.3.5.2.4. By End user
8. Asia Pacific Perinatal Infections Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Infection Type
8.2.2. By Treatment
8.2.3. By Diagnosis
8.2.4. By End user
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Perinatal Infections Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Infection Type
8.3.1.2.2. By Treatment
8.3.1.2.3. By Diagnosis
8.3.1.2.4. By End user
8.3.2. India Perinatal Infections Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Infection Type
8.3.2.2.2. By Treatment
8.3.2.2.3. By Diagnosis
8.3.2.2.4. By End user
8.3.3. Japan Perinatal Infections Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Infection Type
8.3.3.2.2. By Treatment
8.3.3.2.3. By Diagnosis
8.3.3.2.4. By End user
8.3.4. South Korea Perinatal Infections Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Infection Type
8.3.4.2.2. By Treatment
8.3.4.2.3. By Diagnosis
8.3.4.2.4. By End user
8.3.5. Australia Perinatal Infections Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Infection Type
8.3.5.2.2. By Treatment
8.3.5.2.3. By Diagnosis
8.3.5.2.4. By End user
9. Middle East & Africa Perinatal Infections Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Infection Type
9.2.2. By Treatment
9.2.3. By Diagnosis
9.2.4. By End user
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Perinatal Infections Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Infection Type
9.3.1.2.2. By Treatment
9.3.1.2.3. By Diagnosis
9.3.1.2.4. By End user
9.3.2. UAE Perinatal Infections Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Infection Type
9.3.2.2.2. By Treatment
9.3.2.2.3. By Diagnosis
9.3.2.2.4. By End user
9.3.3. South Africa Perinatal Infections Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Infection Type
9.3.3.2.2. By Treatment
9.3.3.2.3. By Diagnosis
9.3.3.2.4. By End user
10. South America Perinatal Infections Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Infection Type
10.2.2. By Treatment
10.2.3. By Diagnosis
10.2.4. By End user
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Perinatal Infections Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Infection Type
10.3.1.2.2. By Treatment
10.3.1.2.3. By Diagnosis
10.3.1.2.4. By End user
10.3.2. Colombia Perinatal Infections Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Infection Type
10.3.2.2.2. By Treatment
10.3.2.2.3. By Diagnosis
10.3.2.2.4. By End user
10.3.3. Argentina Perinatal Infections Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Infection Type
10.3.3.2.2. By Treatment
10.3.3.2.3. By Diagnosis
10.3.3.2.4. By End user
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Perinatal Infections Market: SWOT Analysis
